Candriam S.C.A. Enovis Corp Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$49.5 - $65.92 $392,139 - $522,218	-7,922 Reduced 48.22%	8,506 $454,000
Q4 2022 Feb 13, 2023	SELL	$44.83 - $57.43 $145,204 - $186,015	-3,239 Reduced 16.47%	16,428 $879,000
Q3 2022 Nov 10, 2022	BUY	$46.07 - $60.1 $906,058 - $1.18 Million	19,667 New	19,667 $906,000

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.